Investigational Rotavirus Vaccine In Late-Stage Clinical Trials
Reuters: Sanofi’s Rotavirus vaccine enters late-stage trials
“French drugmaker Sanofi said on Tuesday an investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhea had entered late-stage clinical trials in India. The vaccine is aimed at rotavirus infections which cause gastroenteritis…” (Callus, 10/14).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.